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                                           ABSTRACT 
INTRODUCTION 
Diabetes mellitus (DM) is a chronic metabolic disease that makes many demands on lifestyle 
modification, potentially causes debilitating and life threatening complications and has 
important implications on a patient’s well-being and social life. 
 
The chronic hyperglycaemia of DM is associated with long-term complications with damage 
and failure of various organs. Unlike in acute illnesses, successful management of any 
chronic disease is predominantly patient driven. Diabetic patients are largely responsible for 
their glycaemic control, compliance to treatment and ultimately curbing the complications of 
long standing DM. 
  
There are numerous factors which govern patient’s attitude towards their disease which 
subsequently influences their compliance to treatment. The long-term complications of DM 
can only be prevented by a firm, life-long commitment to a treatment regimen. It is essential 
that patients perceive that this affords them a good health related quality of life (HRQOL), 
and prevents complications and ultimately reduces the noteworthy strain on public health 
funding. 
 
Health care providers should strive to understand that having a chronic disease impacts all 
spheres of a patient’s life, namely physical, emotional, and social. Ideally, such patient-
centred awareness should be incorporated into chronic disease treatment strategies 
designed to improve or enhance daily functioning and hence enhance HRQOL. HRQOL 
might be an important factor to ascertain whether patients will adhere to their prescribed 
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treatment regimen and thus lead to fewer consultations and emergency hospitalizations and 
hence reduce health care costs. 
 
The purpose of this study was to determine whether there is an association between the 
HRQOL and certain indicators of the severity and control of type 2 diabetes at the Diabetic 
Clinic at Helen Joseph Hospital. 
 
OBJECTIVES 
The purpose of this study was to determine whether there is an association between the 
health related quality of life (HRQOL) and certain indicators of severity and control in type 2 
diabetic patients, at the Diabetic Clinic at Helen Joseph Hospital. 
a) To determine the HRQOL of a sample of type 2 diabetic patients. 
 
b)  To describe the demographics (age, gender, smoking pack year history, number of 
alcohol units consumed per week etc.) of the population being studied. 
 
c) To document the following parameters which are important in determining the control 
and  severity of type 2 diabetes: 
 Glycosylated haemoglobin (HbA1C) 
 Determine the patient’s total amount of insulin required per day (if on insulin                            
therapy). 
 Body Mass Index (BMI) 
 Exercise compliance  
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d) To determine whether there is an association between any or all of the above 
parameters and the HRQOL of these patients. 
 
e) To determine the presence of any co-existing diseases and compare HRQOL between 
diabetic  patients with and without co-existing diseases:  
 hypertension (HT) 
 dyslipidaemia  
 
 
RESEARCH DESIGN AND METHODS 
This was a clinical audit, cross-sectional in nature and a descriptive study of patients 
attending the Helen Joseph Hospital, Diabetic Clinic from June to September 2012. The 
study population was a sample of 200 type 2 diabetic patients routinely attending the 
diabetic clinic. 
 
Each patient was given a Diabetes-39 questionnaire, which was then analysed in 
conjunction with data from patient’s file. No incentives were offered for participation nor were 
they discriminated against if they refused to participate.  
 
The questionnaire captured demographic variables such as age, gender, age of diagnosis, 
marital status, exercise regimen, employment status, living arrangements, smoking and 
alcohol habits, height, weight, as well as diabetes-specific variables such as concurrent use 
of antihypertensive medication and/or lipid lowering drugs.  
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The patient’s files were then analysed and various diabetic parameters (HBA1C, lipogram, 
weight, height, number of insulin units used per day and concurrent use of OHA were noted. 
 
RESULTS 
The study found an association between type 2 DM and certain domains of HRQOL. QOL 
was more affected by sexual functioning, anxiety and worry, and diabetes control.  
 
Results also demonstrated an association between HBA1C and HRQOL. Furthermore there 
was an association between HRQOL and HT and dyslipidaemia.  
 
There was no association found between HRQOL and other clinical parameters namely; 
number of insulin units used per day, exercise, BMI, lipogram, or the use of OHA. 
Demographic parameters; age, gender, age at diagnosis, employment status, living 
arrangements were also shown to have no impact on HRQOL in this study. There was also 
no association between HRQOL in patients who consumed alcohol and cigarettes and those 
who did not.  
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